TALARIS THERAPEUTICS INC's ticker is TALS and the CUSIP is 87410C104. A total of 59 filers reported holding TALARIS THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,092,759 | -2.0% | 1,100,626 | +6.0% | 0.00% | – |
| Q2 2023 | $3,155,128 | +49.2% | 1,037,871 | -7.7% | 0.00% | – |
| Q1 2023 | $2,114,900 | +97.1% | 1,124,947 | +7.0% | 0.00% | – |
| Q4 2022 | $1,072,848 | -59.9% | 1,051,811 | +3.4% | 0.00% | – |
| Q3 2022 | $2,675,000 | -41.7% | 1,016,998 | -0.1% | 0.00% | – |
| Q2 2022 | $4,591,000 | -54.7% | 1,018,125 | -1.2% | 0.00% | – |
| Q1 2022 | $10,142,000 | -35.7% | 1,030,742 | -0.0% | 0.00% | – |
| Q4 2021 | $15,761,000 | +194.9% | 1,030,822 | +161.5% | 0.00% | – |
| Q3 2021 | $5,345,000 | -6.9% | 394,178 | +0.9% | 0.00% | – |
| Q2 2021 | $5,741,000 | – | 390,826 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Qiming U.S. Ventures Management, LLC | 2,932,606 | $5,513,299 | 6.67% |
| BML Capital Management, LLC | 1,929,484 | $3,627,430 | 3.14% |
| Western Standard LLC | 586,481 | $1,102,584 | 1.12% |
| Cormorant Asset Management, LP | 900,649 | $1,693 | 0.11% |
| Artal Group S.A. | 914,262 | $1,719 | 0.10% |
| Values First Advisors, Inc. | 52,896 | $99,445 | 0.06% |
| Blackstone Inc. | 8,089,315 | $15,207,912 | 0.06% |
| Eventide Asset Management | 1,561,092 | $2,934,853 | 0.05% |
| Marquette Asset Management, LLC | 101,375 | $190,585 | 0.05% |
| VIKING GLOBAL INVESTORS LP | 3,289,617 | $6,184,480 | 0.03% |